What’s New in Alzheimer Disease Treatment
September 20 @ 12:00 pm - 1:00 pm
FREE
Register to attend here: bit.ly/TWTDSept20
There have been many updates in the treatment of Alzheimer’s Disease recently. Join us on Friday, September 20th as Mike Erkkinen, MD, discusses some of these developments in his presentation, “What’s New in Alzheimer Disease Treatment.”
Dr. Erkkinen will cover:
Lecanemab – Medication approved by the Federal Drug Administration (FDA)
Potential benefits & risks of treatment
An overview of the Mass General Brigham Alzheimer Therapeutic Program (ATP) which is designed to safely deliver new Alzheimer treatments to patients
How patients are watched for potential side effects
Who is eligible for treatment
Dr. Erkkinen is the Director of the Brigham & Women’s Hospital Division of Cognitive & Behavioral Neurology.
This program is part of the MADRC Talk With the Doc(tor) Series.
Register to attend here: bit.ly/TWTDSept20
